Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2025 15:57 ET | Source: PharmAla Biotech

PharmAla Files Preliminary Base Shelf Prospectus

Pharmala files short form prospectus
June 18, 2025 08:30 ET | Source: SaverOne 2014 Ltd.

SaverOne Granted New US Patent Advancing Sensor Fusion Capabilities for Driver Safety

This 14th granted patent out of SaverOne’s full IP portfolio of 23 patents and patent applications demonstrates SaverOne’s technological leadership in mobile device detection and classification within...
June 18, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Commercial Scale up complete for AVERSA
June 10, 2025 09:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China

LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for...
June 09, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

New Patent issuance
June 03, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference

noble conference announcement
June 02, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q1 results
May 27, 2025 07:32 ET | Source: SciSparc Ltd

SciSparc Announces Publication of Japanese Patent Application

TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
May 15, 2025 09:00 ET | Source: PharmAla Biotech

PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform for Novel Phenethylamines

PharmAla launches its Phenesafe AI, a custom-made technology stack allowing it to easily discover new MDMA-like molecules
April 30, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband CEO Publishes Letter to Shareholders

2025 Letter to Shareholders

Next Page keyboard_arrow_right